Theravance Biopharma, Inc. (TBPH)

18.73 +0.16 (+0.86%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Theravance Biopharma Average Diluted Shares Outstanding (Annual)

Average Diluted Shares Outstanding (Annual) Chart

View Average Diluted Shares Outstanding (Annual) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Annual) Range, Past 5 Years

View Average Diluted Shares Outstanding (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Annual) Benchmarks

View Average Diluted Shares Outstanding (Annual) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Skye Bioscience, Inc. Upgrade
FibroGen, Inc. Upgrade
Myomo, Inc. Upgrade